Complement factor D, a novel serine protease

Protein Science

Volumn 5, Issue 4, 1996, Pages 553-564

  Volanakis, John E ^a   Narayana, Sthanam V L ^b  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

alternative complement pathway; catalytic triad; complement; enzyme kinetics; mutagenesis; serine proteases

Indexed keywords

COMPLEMENT FACTOR D; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FACTOR; CONFORMATIONAL TRANSITION; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0029935480     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050401     Document Type: Review

References (71)

1. Bachovchin WW, Roberts JD. 1978. Nitrogen-15 nuclear magnetic resonance spectroscopy. The state of histidine in the catalytic triad of α-lytic protease. Implications for the charge-relay mechanism of peptide-bond cleavage by serine proteases. J Am Chem Soc 100:8041-8047.
2. Barnum SR, Ishii Y, Agrawal A, Volanakis JE. 1992. Production and interferon-γ-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. Biochem J 287:595-601.
3. Barnum SR, Niemann MA, Kearney JF, Volanakis JE 1984. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. J Immunol Meth 67:303-309
4. Barnum SR, Volanakis JE. 1985. In vitro biosynthesis of complement protein D by U937 cells J Immunol 134:1799-1803.
5. Birktoft JJ, Blow DM 1972. Structure of crystalline α-chymotrypsin. V. The atomic structure of Tosyl-α-chymotrypsin at 2 Å resolution. J Mol Biol 68:187-240.
6. Blow DM, Birktoft JJ, Hartley BS 1969. Role of a buried acid group in the mechanism of action of chymotrypsin. Nature 221:337-340.
7. Bode W, Papamokos E, Musil D, Seemueller U, Fritz H. 1986. Refined 1.2 Å crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin C. Molecular structure of eglin and its detailed interaction with subtilisin. EMBO J 5:813-818.
8. Bode W, Walter J, Huber R, Wenzel HR, Tschesche H. 1984. The refined 2.2 Å X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg 15 analogue of bovine pancreatic trypsin inhibitor. Eur J Biochem 144:185-190.
9. Campbell RD, Law SKA, Reid KBM, Sim RB. 1988. Structure, organization, and regulation of complement genes. Annu Rev Immunol 6:161-195.
10. Carson M, Bugg CE. 1986. Algorithm for ribbon models of proteins. J Mol Graph 4:121-122.
11. Carter P, Wells JA. 1988. Dissecting the catalytic triad of a serine protease. Nature 332:564-568
12. Cohen GH, Silverton EW, Davies DR. 1981. Refined crystal structure of γ-chymotrypsin at 1.9 Å resolution. Comparison with other pancreatic serine proteases. J Mol Biol 148:449-479.
13. Cook KS, Groves DL, Min HY, Spiegelman BM. 1985. A developmentally regulated mRNA from 3T3 adipocytes encodes a novel serine protease homologue. Proc Natl Acad Sci USA 82:6480-6484.
14. Corey DR, Craik CS. 1992. An investigation into the minimum requirements for peptide hydrolysis by mutation of the catalytic triad of trypsin. J Am Chem Soc 114:1784-1790.
15. Craik CS, Roczniak S, Largman C, Rutter WJ. 1987. The catalytic role of the active site aspartic acid in serine proteases. Science 237:909-913.
16. Davis AE III, Zalut C, Rosen FS, Alper CA. 1979. Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence. Biochemistry 18:5082-5087.
17. 14C-DIP-trypsin with α-chymotrypsin. Biochim Biophys Acta 19:193-195.
18. Evnin LB, Vásquez JR, Craik CS. 1990. Substrate specificity of trypsin investigated by using a genetic selection. Proc Natl Acad Sci USA 87:6659-6663.
19. Fearon DT, Austen KF, Ruddy S. 1974. Properdin factor D: Characterization of its active site and isolation of the precursor form. J Exp Med 139: 355-366.
20. Fehlhammer H, Bode W, Huber R. 1977. Crystal structure of bovine trypsinogen at 1.8 å resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol 111.415-438.
21. Fujinaga M, James MNG. 1987. Rat submaxillary gland serine protease, tonin - Structure solution and refinement at 1.8 Å resolution. J Mol Biol 195:373-396.
22. Gráf L, Craik CS, Patthy A, Roczniak S, Fletterick RJ, Rutter WJ. 1987. Selective alteration of substrate specificity by replacement of aspanic acid-189 with lysine in the binding pocket of trypsin. Biochemistry 26:2616-2623.
23. Gráf L, Jancsó A, Szilágyi L, Hegyi G, Pintér K, Náray-Szabó G, Hepp J, Medzihradszky K, Rutter WJ. 1988. Electrostatic complementarity in the substrate binding pocket of trypsin. Proc Natl Acad Sci USA 85:4961-4965.
24. Greer J. 1990. Comparative modeling methods. Application to the family of the mammalian serine proteases. Proteins Struct Funct Genet 7:317-334.
25. Hedstrom L, Perona JL, Rutter WJ. 1994. Converting trypsin to chymotrypsin: Residue 172 is a substrate specificity determinant. Biochemistry 33:8757-8763.
26. Hedstrom L, Szilagyi L, Rutter WJ. 1992. Converting trypsin to chymotrypsin: The role of surface loops. Science 255:1249-1253.
27. Huber R, Bode W. 1978. Structural basis of the activation and action of trypsin. Acc Chem Res 11:114-122.
28. Hunsicker LG, Ruddy S, Austen KF. 1973. Alternate complement pathway: Factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol 110:128-138.
29. Inagi R, Miyata T, Oda O, Maeda K, Inoue K. 1994. Evaluation of the proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure. Nephron 66:285-290.
30. Johnson DMA, Gagnon J, Reid KBM. 1984. Amino acid sequence of human factor D of the complement system. Similarity in sequence between factor D and proteases of non-plasma origin. FEBS Lett 166:347-351.
31. Kam CM, Fujikawa K, Powers JC. 1988. Mechanism-based isocoumarin inhibitors for trypsin and blood coagulation serine proteases: New anticoagulants. Biochemistry 27:2547-2557.
32. Kam CM, McRae BJ, Harper JW, Niemann MA, Volanakis JE, Powers JC. 1987. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. J Biol Chem 262:3444-3451.
33. Kam CM, Oglesby TJ, Pangburn MK, Volanakis JE, Powers JC. 1992. Substituted isocoumarins as inhibitors of complement serine proteases. J Immunol 149:163-168.
34. Kim S, Narayana SVL, Volanakis JE. 1994. Mutational analysis of the substrate binding site of human complement factor D. Biochemistry 33: 14393-14399.
35. Kim S, Narayana SVL, Volanakis JE. 1995a. Crystal structure of a complement factor D mutant expressing enhanced catalytic activity. J Biol Chem 270:24399-24405.
36. Kim S, Narayana SVL, Volanakis JE. 1995b. Catalytic role of a surface loop of the complement serine protease factor D. J Immunol 154:6073-6079.
37. Kossiakoff AA, Spencer SA. 1981. Direct determination of the protonation states of aspartic acid-102 and histidine-57 in the tetrahedral intermediate of the serine proteases: Neutron structure of trypsin. Biochemistry 20:6462-6474.
38. Lesavre PH, Muller-Eberhard HJ. 1978. Mechanism of action of factor D of the alternative complement pathway. J Exp Med 148:1498-1509.
39. Liao DI, Breddam K, Sweet RM, Bullock T, Remington SJ. 1992. Refined atomic model of wheat serine carboxypeptidase II at 2.2-Å resolution. Biochemistry 31:9796-9812.
40. Liao DI, Remington SJ. 1990. Structure of wheat serine carboxypeptidase II at 3.5-Å resolution. A new class of serine proteinase. J Biol Chem 265: 6528-6531.
41. McPhalen CA, James MNG. 1988. Structural comparison of two serine proteinase-protein inhibitor complexes: Eglin-C-subtilisin Carlsberg and CI-2-subtilisin Novo. Biochemistry 27:6582-6598.
42. Muller-Eberhard HJ. 1988. Molecular organization and function of the complement system. Annu Rev Biochem 57:321-347.
43. Muller-Eberhard HJ, Götze O. 1972. C3 proactivator convertase and its mode of action. J Exp Med 135:1003-1008.
44. Narayana SVL, Carson M, El-Kabbani O, Kilpatrick JM, Moore D, Chen X, Bugg CE, Volanakis JE, DeLucas LJ. 1994. Structure of human factor D. A complement system protein at 2.0 Å resolution. J Mol Biol 235: 695-708.
45. Navia MA, McKeever BM, Springer JP, Lin TY, Williams HR, Fluder EM, Dorn CP, Hoogsteen K. 1989. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci USA 86:7-11.
46. Neurath H. 1975. Limited proteolysis and zymogen activation. In: Reich E, Rifkins DB, Shaw E, eds. Proteases and biological control, vol 2. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, pp 51-64.
47. Neurath H, Walsh KA. 1976. Role of proteolytic enzymes in biological regulation (A review). Proc Natl Acad Sci USA 75:3825-3832.
48. Niemann MA, Bhown AS, Bennett JC, Volanakis JE. 1984. Amino acid sequence of human D of the alternative complement pathway. Biochemistry 25:2482-2486.
49. Pascual M, Steiger G, Estreicher J, Macon K, Volanakis JE, Schifferli JA. 1988. Metabolism of complement factor D in renal failure. Kidney Int 34:529-536.
50. Perona JJ, Craik CS. 1995. Structural basis of substrate specificity in the serine proteases. Protein Sci 4:337-360.
51. Perona JJ, Hedstrom L, Rutter WJ, Fletterick RJ. 1995. Structural origins of substrate discrimination in trypsin and chymotrypsin. Biochemistry 34:1489-1499.
52. Perona JJ, Hedstrom L, Wagner R, Rutter WJ, Craik CS, Fletterick RJ. 1994 Exogenous acetate reconstitutes the enzymatic activity of Asp189Ser trypsin. Biochemistry 33:3252-3259.
53. Perona JJ, Tsu CA, Craik CS, Fletterick RJ. 1993. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. J Mol Biol 230:919-933.
54. Remington SJ, Woodbury RG, Reynolds RA, Matthews BW, Neurath H. 1988. The structure of rat mast cell protease II at 1.9 Å resolution. Biochemistry 27:8097-8105.
55. Rosen BS, Cook KS, Yaglom J, Groves DL, Volanakis JE, Damm D, White T, Spiegelman BM. 1989. Adipsin and complement factor D activity: An immune-related defect in obesity. Science 244:1483-1487.
56. Ruhlman A, Kukla D, Schwager P, Bartels K, Huber R. 1973. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. J Mol Biol 77:417-436.
57. Sanders PW, Volanakis JE, Rostand SG, Galla JH. 1986. Human complement protein D catabolism by the rat kidney J Clin Invest 77:1299-1304.
58. Sawyer L, Shotton DM, Campbell JW, Wendell PL, Muirhead H, Watson HC, Diamond R, Ladner RC. 1978. The atomic structure of crystalline porcine pancreatic elastase at 2.5 Å resolution. Comparisons with the structure of α-chymotrypsin. J Mol Biol 118:137-208.
59. Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157-162.
60. α-tosyl-L-lysine. Biochemistry 4:2219-2224.
61. 102 in serine protease catalysis. Science 237:905-909.
62. Steiner DF, Smeekens SP, Ohagi S, Chan SJ. 1992. The new enzymology of precursor processing endoproteases. J Biol Chem 267:23435-23438.
63. Vernet T, Tessier DC, Richardson C, Laliberté F, Khouri HE, Bell AW, Storer AC, Thomas DY. 1990. Secretion of functional papain precursor from insect cells. Requirement for N-glycosylation of the pro-region. J Biol Chem 265:16661-16666.
64. Volanakis JE, Barnum SR, Giddens M, Galla JH. 1985. Renal filtration and catabolism of complement protein D. N Engl J Med 312:395-399.
65. Volanakis JE, Macon KJ. 1987. Isolation of complement protein D from urine of patients with Fanconi's syndrome. Anal Biochem 163:242-246.
66. Warshel A, Naray-Szabo G, Sussman F, Hwang JK. 1989. How do serine proteases really work? Biochemistry 28:3629-3637.
67. Whaley K. 1980. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med 151:501-516.
68. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. 1992. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 267: 9210-9213.
69. Wright CS. 1972. Comparison of the active site stereochemistry and substrate conformation in α-chymotrypsin and subtilisin BPN'. J Mol Biol 67:151-163.
70. Wright CS, Alden RA, Kraut J 1969. Structure of subtilisin BPN' at 2.5 Å resolution. Nature 221:235-242.
71. Yamauchi Y, Stevens JW, Macon KJ, Volanakis JE. 1994. Recombinant and native zymogen forms of human complement factor D. J Immunol 152: 3645-3653.